Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...
Lupin share price fell nearly 2 percent in the early trade on February 11 despite the company received United States Food and Drug Administration (USFDA) approval for nasal spray. At 09:23am ...
Grasim Industries, the flagship entity of the Aditya Birla Group, posted a consolidated net loss of ₹ 168.7 crore for Q3 FY25 ...
Lupin receives US FDA approval for generic Atrovent nasal spray, 0.06%: Our Bureau,Mumbai Tuesday, January 28, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin) anno ...
Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...
Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...
Shares of Lupin Ltd dropped 2.8% despite a significant Q3 profit increase of 38.8% year-on-year. The company's revenue surged ...
Stocks including Eicher Motors, Lupin, MTAR Technologies, Aditya Birla Capital, Nykaa, Bata india, SBFC Finance, Samhi Hotels ...
Lupin: The pharma major received approval from the USFDA for its abbreviated new drug application for Ipratropium Bromide Nasal Solution (Nasal Spray) to market a generic equivalent. The product ...
Discover how the dry air of winter affects your nose and how to combat the drying out with helpful tips and treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results